Jagsonpal Pharmaceuticals, a company in the Pharmaceuticals industry, reported revenue of ₹81 crore and net profit of ₹13 crore for the September 2026 quarter.
Jagsonpal Pharmaceuticals (NSE: JAGSNPHARM) closed at ₹209.27 on 20 Nov 2026, up 1.7% over the past year. Its market capitalisation is ₹1,382 crore and it trades at 29.3 times earnings.
Incorporated in 1978, Jagsonpal Pharmaceuticals Ltd manufactures and trades pharmaceutical products and active pharmaceutical ingredients
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.